Consumer goods giant Nestlé is in talks to sell its skin health business to private equity firm EQT and the Abu Dhabi Investment Authority for $10.1 billion, The Wall Street Journal reported.

National health spending reached $3.76 trillion in March 2019, a 4.6% jump from the same month in 2018, according to recent data from Altarum, underscoring signs of acceleration during the first quarter of 2019.

JPMorgan Chase has acquired InstaMed, a technology company with a focus in healthcare payments, for a purchase price of more than $500 million.

Avoidable hospital deaths are on the decline, according to recent estimates from the Leapfrog Group for Johns Hopkins University School of Medicine.

The American Hospital Association has outlined a seven-step approach specifically tailored to health system leaders to address burnout in healthcare.

A San Jose-based company focused on machine learning for care optimization, Health[at]Scale, has raised $16 million in a Series A funding round, with Optum as its sole investor.

CMS finalized a rule that aims to boost transparency of the cost of prescription drugs in Medicare Part D and enable Medicare Advantage plans to negotiate better prices for medicines. Notably, the final version backs off a controversial proposal that would have allowed Medicare Part D plans to exclude certain drugs if prices rise beyond a threshold.

A top executive at the healthcare joint venture between Amazon, Berkshire Hathaway and JPMorgan Chase––Haven––has stepped down, according to CNBC. Chief operating officer Jack Stoddard, formerly general manager for digital health at Comcast, is reportedly leaving his position for personal reasons after just nine months at the company.